| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/19/2004 | EP1419784A2 Proteosome vaccines against toxins, allergy and cancer |
| 05/19/2004 | EP1419783A2 Use of a composition comprising an exendin or a compound derived therefrom and a pharmaceutical carrier |
| 05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/19/2004 | EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission |
| 05/19/2004 | EP1419769A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419177A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 05/19/2004 | EP1419173A2 Peptides that bind to atherosclerotic lesions |
| 05/19/2004 | EP1419168A2 Antisense modulation of apolipoprotein b expression |
| 05/19/2004 | EP1419161A1 Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1418935A1 Genobix agonists and antagonists for use in the treatment of metabolic disorders |
| 05/19/2004 | EP1418934A1 Xobesin agonists and antagonists for the treatment of metabolic disorders |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418915A1 Neuroprotective drug |
| 05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1418904A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1418897A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 05/19/2004 | EP1418876A2 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 05/19/2004 | EP1263745B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1079841A4 Method of extracting antioxidants from labiate species and the extract products thereof |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE202004004618U1 Composition containing bilberry extract, useful for treating headache and migraine, also contains antioxidants and micronutrients |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | DE10250710A1 Neue Verwendung von Dioxocin-5-on-Derivaten New use of dioxocin-5-one derivatives |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | DE10250412A1 Orally administered herbal hypoglycemic agent, useful for treating type II diabetes mellitus, comprising leaves or stems of Sorbus genus plants, preferably mountain ash |
| 05/19/2004 | CN1498237A Process for preparing lactic acid oligomer |
| 05/19/2004 | CN1498222A Steroidal derivatives |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498113A Insulin preparations, which donot contain any zinc or only small quantity of zinc of improved stability |
| 05/19/2004 | CN1498084A Low glycemic response compositions |
| 05/19/2004 | CN1496982A Imidazoline compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496741A Method for producing enteric nutrient containing malt ketose |
| 05/19/2004 | CN1496738A Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 05/19/2004 | CN1150217C Cross-linked polymer and its application |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1150159C Intermediate for preparing allyl quinone derivative and prep. of the same |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150011C 'Qingzhang Mingmu' pills for clearing eyes and its preparation method |
| 05/19/2004 | CN1150010C Method for removing farm chemical ingredients from ginseng extract |
| 05/19/2004 | CN1150000C Compositions containing diphosphonic acids |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/19/2004 | CN1149981C Product with powder stable vitamine and/or carotenoid its producing process |
| 05/18/2004 | US6737442 Food compositions for reducing insulin resistance |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737414 Composition for enteral nutrition comprising fibres |
| 05/18/2004 | US6737407 Treatment of obesity |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737045 Methods and compositions for the pulmonary delivery insulin |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004039759A1 A natural compound useful for treating diabetes, its preparation and use |
| 05/13/2004 | WO2004039405A1 Use of sglt homolog |
| 05/13/2004 | WO2004039389A1 SELECTIVE HUMAN β3 ADRENALIN RECEPTOR AGONIST AGENT |
| 05/13/2004 | WO2004039388A1 α-GLUCOSIDASE INHIBITOR |
| 05/13/2004 | WO2004039373A1 Iminosugar derivatives as glucosidase inhibitors |
| 05/13/2004 | WO2004039364A1 Novel use of dioxocin-5-on derivatives |
| 05/13/2004 | WO2004039362A2 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 05/13/2004 | WO2004033416A3 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
| 05/13/2004 | WO2004024183B1 Immunization against autologous ghrelin |
| 05/13/2004 | WO2004024167A3 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type ii diabetes |
| 05/13/2004 | WO2004022074A8 Nutritional compositions comprising a non-glucose carbohydrate or pectin and soluble fiber |
| 05/13/2004 | WO2004018467A3 Phenacyl xanthine derivatives as dpp-iv inhibitor |
| 05/13/2004 | WO2004002461A3 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 05/13/2004 | WO2003101449A3 Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |